normal or sodium 117±10mmol/day No baseline high BP tablets/day) data to calculate Reduced change in sodium diet + ambulatory BP placebo (control group) Key features for bias assessment of randomised trials Citation Method of Allocation Blinding Loss to Use of Ceasing study Reporting all Funding randomisation concealment follow-up early for benefit outcome source where results required Suckling et Unclear (not Unclear (not Participants: Unclear unclear Unclear Unclear Unclear al (2010) enough enough unclear information in information in *conference Providers: abstract) abstract) abstract Unclear Outcome assessors: Unclear Summary table
normal or high BP sodium tablets/day) Reduced sodium diet + placebo (control group) 117±10mmol/day No baseline data to calculate change in ambulatory BP Key features for bias assessment of randomised trials Citation Method of randomisation Allocation concealment Blinding Loss to follow-up Use of where required Ceasing study early for benefit Reporting all outcome results Funding source Suckling et al (2010) *conference abstract Unclear (not enough information in abstract) Unclear (not enough information in abstract) Participants: unclear Providers: Unclear Outcome assessors: Unclear Unclear unclear Unclear Unclear Unclear Summary table
Sodium%20Supporting%20Document%201%20%20Systematic%20Literature%20Review.docx